tlooto
Sign up
MedicinePhysics

Comment on “Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study”

K. Shridevi, Megha Doiphode, Rakhi Mishra, A. Dhyani

2026.4.7ANNALS OF NUCLEAR MEDICINE

DOI: 10.1007/s12149-026-02206-z

Abstract

Abstract is not available.

Citation format

SHRIDEVI, K., et al. Comment on “long-term efficacy and safety of peptide receptor radionuclide therapy in japanese patients with unresectable neuroendocrine tumor: Extension of the japanese phase i and phase I/II study”. ANNALS OF NUCLEAR MEDICINE, 2026, 40(6): 731–732.